Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT) [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether apixaban, warfarin, and aspirin can prevent portal vein thrombosis after laparoscopic splenectomy in patients with cirrhosis; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Coumadin (warfarin)
  • Eliquis (apixaban)

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: Cirrhosis, Splenectomy; Status | Phase 4 | Status: COMPLETED